Cross-platform method for identifying candidate network biomarkers for prostate cancer.

Area of Science:

• Biomolecular research
• Bioinformatics
• Molecular diagnostics

Background:

• Biomarker discovery using mass spectrometry (MS) and microarray expression profiles is crucial for molecular diagnosis.
• Existing methods may lack confidence and reliability in identifying robust biomarkers.

Purpose of the Study:

• To propose a new pipeline for biomarker discovery integrating diverse biological data.
• To identify high-confidence network biomarkers for prostate cancer.

Main Methods:

• Developed a pipeline integrating disease information, genomic and proteomic expression profiles, and protein-protein interactions (PPIs).
• Applied the pipeline to identify molecules related to prostate cancer.
• Constructed a prostate-cancer-related network (PCRN) using integrated information.

Main Results:

• Identified 474 molecules (genes and proteins) associated with prostate cancer.
• Derived a prostate-cancer-related network (PCRN) from integrated data.
• Candidate network biomarkers were identified from eight microarray and one proteomics dataset.

Conclusions:

• Network biomarkers, incorporating PPIs, accurately distinguish prostate cancer patients from healthy individuals.
• The proposed pipeline offers a more reliable approach to biomarker candidate identification compared to conventional methods.